日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Diagnostic performance of artificial intelligence models for pulmonary nodule classification: a multi-model evaluation

人工智能模型在肺结节分类中的诊断性能:多模型评估

Herber, Sarah K; Müller, Lukas; Pinto Dos Santos, Daniel; Jorg, Tobias; Souschek, Fabio; Bäuerle, Tobias; Foersch, Sebastian; Galata, Christian; Mildenberger, Peter; Halfmann, Moritz C

Evaluation of a Clinical Decision Support System for Imaging Requests: A Cluster Randomized Clinical Trial

影像检查申请临床决策支持系统的评估:一项整群随机临床试验

Dijk, Stijntje W; Wollny, Claudia; Barkhausen, Joerg; Jansen, Olav; Mildenberger, Peter; Halfmann, Moritz C; Stroeder, Jonas; Rizopoulos, Dimitris; Hunink, M G Myriam; Kroencke, Thomas

An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant

编码SARS-CoV-2 Omicron XBB.1.5受体结合域的mRNA疫苗可保护小鼠免受JN.1变异株的感染。

Ryuta Uraki ,Maki Kiso ,Mutsumi Ito ,Seiya Yamayoshi ,Peter Halfmann ,Shilpi Jain ,Mehul S Suthar ,Tiago J S Lopes ,Nao Jounai ,Kazuki Miyaji ,Fumihiko Takeshita ,Yoshihiro Kawaoka

A broadly-neutralizing antibody against Ebolavirus glycoprotein that potentiates the breadth and neutralization potency of other antibodies

针对埃博拉病毒糖蛋白的广泛中和抗体,可增强其他抗体的广度和中和效力

Francesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, Victoria O'Dowd, Amar Parvate, Heather Callaway, Chitra Hariharan, Dipti Parekh, Sean Hui, Kelly Shaffer, Ruben Diaz Avalos, Kathryn Hastie, Lisa Schimanski, Helena Müller-Kräuter, Thomas Strecker, Ariane Balaram, Peter Halfmann, Erica Ollm

Assembly of Immunogenic Protein Particles toward Advanced Synthetic Vaccines

免疫原性蛋白颗粒的组装及高级合成疫苗

Shuxiong Chen, Diana H Quan, Gayathri Sam, Victoria Ozberk, Xiaonan T Wang, Peter Halfmann, Manisha Pandey, Michael F Good, Yoshihiro Kawaoka, Warwick J Britton, Bernd H A Rehm

Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membrane

具有空前效力的抗埃博拉病毒 mAb 3A6 可保护高病毒血症动物免于死亡,并从病毒体膜上物理提升其糖蛋白靶标

Erica Saphire, Zhe Li Salie, Zunlong Ke, Peter Halfmann, Lisa Evans DeWald, Sara McArdle, Ariadna Grinyo, Edgar Davidson, Sharon Schendel, Chitra Hariharan, Michael Norris, Xiaoying Yu, Chakravarthy Chennareddy, Xiaoli Xiong, Megan Heinrich, Michael Holbrook, Benjamin Doranz, Ian Crozier, Kathryn Ha

Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters

SARS-CoV-2 omicron 变体对仓鼠的致病性降低

Katherine McMahan, Victoria Giffin, Lisa H Tostanoski, Benjamin Chung, Mazuba Siamatu, Mehul S Suthar, Peter Halfmann, Yoshihiro Kawaoka, Cesar Piedra-Mora, Neharika Jain, Sarah Ducat, Swagata Kar, Hanne Andersen, Mark G Lewis, Amanda J Martinot, Dan H Barouch

A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs

一种减少 SARS-CoV-2 和季节性 HCoV ELISA 梯度稀释检测工作量的新方法

David Pattinson, Peter Jester, Lizheng Guan, Seiya Yamayoshi, Shiho Chiba, Robert Presler, Hongyu Rao, Kiyoko Iwatsuki-Horimoto, Nobuhiro Ikeda, Masao Hagihara, Tomoyuki Uchida, Keiko Mitamura, Peter Halfmann, Gabriele Neumann, Yoshihiro Kawaoka

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2

SARS-CoV-2 Omicron/BA.2 的表征和抗病毒敏感性

Yoshihiro Kawaoka, Ryuta Uraki, Maki Kiso, Shun Iida, Masaki Imai, Emi Takashita, Makoto Kuroda, Peter Halfmann, Samantha Loeber, Tadashi Maemura, Seiya Yamayoshi, Seiichiro Fujisaki, Zhongde Wang, Mutsumi Ito, Michiko Ujie, Kiyoko Iwatsuki-Horimoto, Yuri Furusawa, Ryan Wright, Zhenlu Chong, Seiya O

Novel modulators of p53-signaling encoded by unknown genes of emerging viruses

新兴病毒未知基因编码的p53信号通路新型调节因子

Dina Alzhanova ,Kathleen Corcoran ,Aubrey G Bailey ,Kristin Long ,Sharon Taft-Benz ,Rachel L Graham ,Grant S Broussard ,Mark Heise ,Gabriele Neumann ,Peter Halfmann ,Yoshihiro Kawaoka ,Ralph S Baric ,Blossom Damania ,Dirk P Dittmer